IL43623A - Drug composition comprising crystallized insulin and amorphous desphenylalanine b1 insulin having antidiabetic activity - Google Patents

Drug composition comprising crystallized insulin and amorphous desphenylalanine b1 insulin having antidiabetic activity

Info

Publication number
IL43623A
IL43623A IL43623A IL4362373A IL43623A IL 43623 A IL43623 A IL 43623A IL 43623 A IL43623 A IL 43623A IL 4362373 A IL4362373 A IL 4362373A IL 43623 A IL43623 A IL 43623A
Authority
IL
Israel
Prior art keywords
insulin
composition
amorphous
crystallized
preparations
Prior art date
Application number
IL43623A
Other languages
English (en)
Other versions
IL43623A0 (en
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL43623A0 publication Critical patent/IL43623A0/xx
Publication of IL43623A publication Critical patent/IL43623A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
IL43623A 1972-11-16 1973-11-13 Drug composition comprising crystallized insulin and amorphous desphenylalanine b1 insulin having antidiabetic activity IL43623A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2256215A DE2256215C3 (de) 1972-11-16 1972-11-16 Insulin-Zubereitung mit einem Gehalt an kristallinem Insulin und amorphem Desphenylalanin8' -insulin

Publications (2)

Publication Number Publication Date
IL43623A0 IL43623A0 (en) 1974-03-14
IL43623A true IL43623A (en) 1976-12-31

Family

ID=5861919

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43623A IL43623A (en) 1972-11-16 1973-11-13 Drug composition comprising crystallized insulin and amorphous desphenylalanine b1 insulin having antidiabetic activity

Country Status (17)

Country Link
US (1) US3937820A (hu)
JP (1) JPS4980223A (hu)
AT (1) AT330345B (hu)
BE (1) BE807417A (hu)
CA (1) CA998338A (hu)
DE (1) DE2256215C3 (hu)
DK (1) DK136292C (hu)
EG (1) EG11577A (hu)
FR (1) FR2206933B1 (hu)
GB (1) GB1450598A (hu)
HU (1) HU170275B (hu)
IE (1) IE38514B1 (hu)
IL (1) IL43623A (hu)
NL (1) NL7315379A (hu)
NO (1) NO137845C (hu)
SE (1) SE419824B (hu)
ZA (1) ZA738743B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2459515C3 (de) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Arzneimittelzubereitungen mit antidiabetischer Wirkung
DE3033127A1 (de) * 1980-09-03 1982-04-08 Hoechst Ag, 6000 Frankfurt Neue analoga des insulins
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
US5547929A (en) * 1994-09-12 1996-08-20 Eli Lilly And Company Insulin analog formulations
WO1997005166A1 (en) 1995-07-25 1997-02-13 Novartis Ag Transforming growth factor beta crystals

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3364116A (en) * 1964-11-02 1968-01-16 Squibb & Sons Inc Method of use of desalanino insulin compositions
EG10440A (en) * 1970-02-07 1977-09-30 Hoechst Ag Process for the preparation of des-phenylalamin b1-insuli

Also Published As

Publication number Publication date
IE38514B1 (en) 1978-03-29
DE2256215C3 (de) 1981-01-08
DK136292C (da) 1978-02-20
BE807417A (fr) 1974-05-16
DE2256215A1 (de) 1974-05-30
HU170275B (hu) 1977-05-28
NO137845B (no) 1978-01-30
US3937820A (en) 1976-02-10
DK136292B (da) 1977-09-26
JPS4980223A (hu) 1974-08-02
AT330345B (de) 1976-06-25
NL7315379A (hu) 1974-05-20
AU6250573A (en) 1975-05-15
NO137845C (no) 1978-05-10
ZA738743B (en) 1974-09-25
DE2256215B2 (de) 1980-04-17
GB1450598A (en) 1976-09-22
IE38514L (en) 1974-05-16
FR2206933A1 (hu) 1974-06-14
FR2206933B1 (hu) 1977-10-28
ATA961973A (de) 1975-09-15
SE419824B (sv) 1981-08-31
CA998338A (en) 1976-10-12
EG11577A (en) 1977-09-30
IL43623A0 (en) 1974-03-14

Similar Documents

Publication Publication Date Title
DE69816409T2 (de) Kristallines Parathyroidhormon
US3868358A (en) Protamine-insulin product
US5547930A (en) AspB28 insulin crystals
EP0133285B1 (de) Insulin-Derivat-Kristallsuspensionen, Verfahren zu deren Herstellung und deren Verwendung
US3917824A (en) Pharmaceutical compositions containing epidermal growth factor or closely related derivatives thereof for inhibiting the secretion of acidic gastric juice in warm blooded animals
US5028586A (en) Insulin derivatives and pharmaceutical preparations containing these derivatives
US5177058A (en) Pharmaceutical formulation for the treatment of diabetes mellitus
JP4353544B2 (ja) アミリン作動薬ペプチド用製剤
DE2600971C2 (de) Verfahren zur Herstellung von Rinder-Insulin-Komplexen mit Dauerwirkung und diese Komplexe enthaltende Arzneimittel
KR960000922A (ko) 안정한 아연 인슐린 유사 결정의 제조
AR020047A1 (es) Composiciones insolubles de insulina, formulaciones en suspension que incluyen dicha composicion insoluble de insulina; y el uso de dicha composicionpara preparar medicamentos y procedimiento para preparar dichas composiciones insolubles.
AU562803B2 (en) Oral antidiabetic composition
KR900017580A (ko) 표피 성장 인자를 함유하는 안정화된 조성물
WO1995005848A1 (en) Protracted glp-1
EP0747092A3 (en) Dissolution liquid for drug in iontophoresis
DE69919533T2 (de) Proteinhaltige arzneimittel
US5028587A (en) Mixed crystals of insulin and insulin derivatives
US2849370A (en) Injectable insulin preparations with protracted effect and process of producing same
GB1458414A (en) Composition and method of treatin ulcers
IL43623A (en) Drug composition comprising crystallized insulin and amorphous desphenylalanine b1 insulin having antidiabetic activity
GB1140400A (en) Therapeutic compositions and a process for the manufacture thereof
DE1792196A1 (de) Verfahren zur Stabilisierung eines Proteins
JPH04244022A (ja) 甲状腺刺激ホルモン抑制および甲状腺腫治療用薬剤
DE3362246D1 (en) Magnesium salt of chenodeoxycholic acid and ursodeoxycholic acid, the process for its preparation, and therapeutic compositions which contain it as active principle
CA1308358C (en) Antibacterial lyophilized preparation